Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Pharmacovigilance is vital for monitoring adverse drug reactions (ADRs) and ensuring drug safety. Traditional methods are slow and inconsistent, but artificial intelligence (AI), through automation and advanced analytics, improves efficiency and accuracy in managing increasing data complexity.
Aim: To explore AI's practical applications in pharmacovigilance, focusing on efficiency, process acceleration, and task automation. It also examines the use of an expert-defined Bayesian network for causality assessment in a Pharmacovigilance Centre, demonstrating its impact on decision-making.
Method: A comprehensive literature narrative review was conducted in MEDLINE (via PubMed), Scopus, and Web of Science using a set of targeted keywords, including but not limited to "pharmacovigilance", "artificial intelligence", "adverse drug reactions" and "drug safety". Relevant studies were analysed without restrictions on publication year or language. The search was carried out in January 2025.
Results: AI has greatly improved pharmacovigilance by streamlining signal detection, surveillance, and ADR reporting automation. Techniques like data mining and automated signal detection have expedited safety signal identification, while duplicate detection has enhanced data precision in safety evaluations. AI has also refined real-world evidence analysis, deepening drug safety and efficacy insights. Predictive models now anticipate ADRs and drug-drug interactions, enabling proactive patient care. At a regional pharmacovigilance center, the implementation of an expert-defined Bayesian network has optimized causality assessment, reducing processing times from days to hours, minimizing subjectivity, and improving the reliability of drug safety evaluations.
Conclusion: AI holds significant promise for enhancing pharmacovigilance practices, yet its practical application remains primarily confined to academic research, with integration hindered by data quality issues, regulatory barriers, and the need for more transparent algorithms.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335403 | PMC |
| http://dx.doi.org/10.1007/s11096-025-01975-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool.
Int J Clin Pharm
August 2025
Algarve Biomedical Centre Research Institute (ABC-Ri), University of Algarve, Faro, Portugal.
Background: Pharmacovigilance is vital for monitoring adverse drug reactions (ADRs) and ensuring drug safety. Traditional methods are slow and inconsistent, but artificial intelligence (AI), through automation and advanced analytics, improves efficiency and accuracy in managing increasing data complexity.
Aim: To explore AI's practical applications in pharmacovigilance, focusing on efficiency, process acceleration, and task automation.
Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network.
Artif Intell Med
September 2018
CINTESIS - Centre for Health Technology and Services Research, Rua Dr. Plácido Costa, 4200-450 Porto, Portugal; UFN - Northern Pharmacovigilance Centre (INFARMED), Rua Dr. Plácido Costa, 4200-450 Porto, Portugal.
In pharmacovigilance, reported cases are considered suspected adverse drug reactions (ADR). Health authorities have thus adopted structured causality assessment methods, allowing the evaluation of the likelihood that a drug was the causal agent of an adverse reaction. The aim of this work was to develop and validate a new causality assessment support system used in a regional pharmacovigilance centre.
View Article and Find Full Text PDFA preliminary approach to quantifying the overall environmental risks posed by development projects during environmental impact assessment.
PLoS One
September 2017
CSIRO Land and Water, Dutton Park, Queensland, Australia.
Environmental impact assessment (EIA) is used globally to manage the impacts of development projects on the environment, so there is an imperative to demonstrate that it can effectively identify risky projects. However, despite the widespread use of quantitative predictive risk models in areas such as toxicology, ecosystem modelling and water quality, the use of predictive risk tools to assess the overall expected environmental impacts of major construction and development proposals is comparatively rare. A risk-based approach has many potential advantages, including improved prediction and attribution of cause and effect; sensitivity analysis; continual learning; and optimal resource allocation.
View Article and Find Full Text PDFApportionment of nitrate (NO) sources in surface water and classification of monitoring locations according to NO polluting activities may help implementation of water quality control measures. In this study, we (i) evaluated a Bayesian isotopic mixing model (stable isotope analysis in R [SIAR]) for NO source apportionment using 2 yr of δN-NO and δO-NO data from 29 locations within river basins in Flanders (Belgium) and five expert-defined NO polluting activities, (ii) used the NO source contributions as input to an unsupervised learning algorithm (k-means clustering) to reclassify sampling locations into NO polluting activities, and (iii) assessed if a decision tree model of physicochemical data could retrieve the isotope-based and expert-defined classifications. Based on the SIAR and δB results, manure/sewage was identified as a major NO source, whereas soil N, fertilizer NO, and NH in fertilizer and rain were intermediate sources and NO in precipitation was a minor source.
View Article and Find Full Text PDFA comparison of methods for assessing penetrating trauma on retrospective multi-center data.
J Biomed Inform
April 2009
University of Toronto, Faculty of Medicine, Toronto, Ont., Canada.
Objective: TraumaSCAN-Web (TSW) is a computerized decision support system for assessing chest and abdominal penetrating trauma which utilizes 3D geometric reasoning and a Bayesian network with subjective probabilities obtained from an expert. The goal of the present study is to determine whether a trauma risk prediction approach using a Bayesian network with a predefined structure and probabilities learned from penetrating trauma data is comparable in diagnostic accuracy to TSW.
Methods: Parameters for two Bayesian networks with expert-defined structures were learned from 637 gunshot and stab wound cases from three hospitals, and diagnostic accuracy was assessed using 10-fold cross-validation.